Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
152.84
+2.96
+(1.97%)
At close: February 21 at 9:55:02 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 14 | 17 |
| Avg. Estimate | 2.2B | 2.39B | 9.35B | 10.04B |
| Low Estimate | 2.16B | 2.37B | 9.28B | 9.74B |
| High Estimate | 2.27B | 2.44B | 9.69B | 10.64B |
| Year Ago Sales | 2.19B | 2.36B | 9.26B | 9.35B |
| Sales Growth (year/est) | 0.53% | 1.06% | 1.01% | 7.43% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ZOE.F | -- | -- | -- | -- |
| S&P 500 | 14.39% | 7.67% | 10.93% | 14.14% |
Upgrades & Downgrades
| Maintains | Barclays: Overweight to Overweight | 2/14/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 2/14/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 2/10/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 1/29/2025 |
| Maintains | Stifel: Buy to Buy | 1/7/2025 |
| Initiated | UBS: Neutral | 12/10/2024 |